Today, the Chairman of iCo Therapeutics (ICOTF), William Wasyl Jarosz, bought shares of ICOTF for $9,574.
This recent transaction increases William Wasyl Jarosz’s holding in the company by 39% to a total of $35.16K.
See today’s analyst top recommended stocks >>
Currently, iCo Therapeutics has an average volume of 100.00K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
iCo Therapeutics, Inc. engages in the business of identification, development and commercialization of drug candidates for the treatment of sight- and life-threatening diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA.